NOAC Monotherapy Non-Inferior to Combination Therapy for Net Adverse Clinical events in AF Patients Post–DES: ADAPT AF-DES Trial
Key Points The ADAPT AF-DES randomized trial compared NOAC monotherapy (apixaban or…
Tag: NOAC
Key Points The ADAPT AF-DES randomized trial compared NOAC monotherapy (apixaban or…